IRIS
TARTAGLIONE, Immacolata
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 741
NA - Nord America 737
AS - Asia 141
OC - Oceania 2
AF - Africa 1
SA - Sud America 1
Totale 1.623
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 733
IE - Irlanda 296
IT - Italia 200
SG - Singapore 71
GB - Regno Unito 66
DE - Germania 59
CN - Cina 49
UA - Ucraina 29
FR - Francia 23
GR - Grecia 21
FI - Finlandia 12
SE - Svezia 11
BE - Belgio 9
PK - Pakistan 9
CH - Svizzera 7
TR - Turchia 6
ID - Indonesia 3
AU - Australia 2
CA - Canada 2
CZ - Repubblica Ceca 2
NI - Nicaragua 2
NL - Olanda 2
BR - Brasile 1
ET - Etiopia 1
HU - Ungheria 1
IN - India 1
LU - Lussemburgo 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
TW - Taiwan 1
Totale 1.623
Salva come PNG Salva come JPEG
Città #
Dublin 287
Chandler 122
Santa Clara 93
Jacksonville 65
Singapore 55
Caserta 43
New York 40
Princeton 38
Roxbury 38
Ann Arbor 36
Bremen 33
Grumo Nevano 21
Cambridge 20
Medford 19
Beijing 18
Naples 18
Wilmington 17
Woodbridge 17
Ashburn 13
Des Moines 13
Munich 12
Boardman 10
Nanjing 10
Brussels 9
Helsinki 9
Milan 8
Napoli 8
Pozzuoli 8
Redwood City 7
Rome 7
Nanchang 6
London 5
Orlando 5
Fairfield 4
San Mateo 4
Istanbul 3
Los Angeles 3
Tianjin 3
Aversa 2
Bandung 2
Brno 2
Elora 2
Kunming 2
Leawood 2
Managua 2
Oxford 2
Pagani 2
Shanghai 2
Amsterdam 1
Auburn Hills 1
Belgrade 1
Bologna 1
Brindisi 1
Cacule 1
Changchun 1
Council Bluffs 1
Florence 1
Francolise 1
Giugliano In Campania 1
Gravesend 1
Gunzenhausen 1
Hanover 1
Houston 1
Hyderabad 1
Imola 1
Jakarta 1
Jinan 1
Lahore 1
Luxembourg 1
Marano Di Napoli 1
Morgan Hill 1
Mountain View 1
Muro Lucano 1
Nanning 1
Ningbo 1
Nocera Superiore 1
Oberuzwil 1
Olbia 1
Padova 1
Poirino 1
Quarto 1
Ramallah 1
Sant'antonio Abate 1
Sarno 1
Seattle 1
Sevastopol 1
Shenyang 1
Taipei 1
Taizhou 1
Tettnang 1
Treviso 1
Turin 1
Vicenza 1
Wuhan 1
Totale 1.193
Salva come PNG Salva come JPEG
Nome #
Cognitive, Brain and Intracranial Artery Involvement in Beta Thalassemia 119
Effects of germline VHL deficiency on growth, metabolism, and mitochondria 88
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. 75
Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload 75
Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function 61
Asymptomatic intracranial aneurysms in beta-thalassemia: A three-year follow-up report 60
Long-term efficacy of deferasirox for cardiac siderosis in thalassemia major 53
Auditory cortex hypoperfusion: a metabolic hallmark in Beta Thalassemia 53
A Novel 12q13.2-q13.3 Microdeletion Syndrome With Combined Features of Diamond Blackfan Anemia, Pierre Robin Sequence and Klippel Feil Deformity 52
Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study 51
Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience 51
Long term efficacy of iron chelation therapy with deferasirox on endocrine function in thalassemia major 50
BONE MINERAL DENSITY IMPROVEMENT IN PATIENTS WITH THALASSEMIA MAJOR ON LONG-TERM CHELATION THERAPY WITH DEFERASIROX 46
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multicentre nation-wide cohort 46
Brain functional impairment in beta-thalassaemia: the cognitive profile in Italian neurologically asymptomatic adult patients in comparison to the reported literature 45
Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with beta-thalassemia. 44
Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: a retrospective cohort study of A.I.E.O.P. patients (Associazione Italiana Emato-Oncologia Pediatrica) 43
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia. 43
No evidence of increased cerebrovascular involvement in adult neurologically-asymptomatic β-Thalassaemia. A multicentre multimodal magnetic resonance study 43
An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research 42
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort 42
A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis 38
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort 38
Headache in beta-thalassemia: An Italian multicenter clinical, conventional MRI and MR-angiography case-control study 37
Crushed deferasirox film-coated tablets in pediatric patients with transfusional hemosiderosis: Results from a single-arm, interventional phase 4 study (MIMAS) 36
Hearing loss in beta-thalassemia: Systematic review 34
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-Thalassemia. 34
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection 33
White matter volume changes in adult beta-thalassemia: Negligible and unrelated to anemia and cognitive performances 32
No increased cerebrovascular involvement in adult beta-thalassemia by advanced MRI analyses 30
Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds 30
Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and Ghana 25
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy 23
Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies 21
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry 18
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 17
Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence 15
Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited 15
Renal safety under long-course deferasirox therapy in iron overloaded transfusion-dependent β-thalassemia and other anemias 14
Brain perfusion changes in beta-thalassemia 13
Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: Phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study 13
Childhood Multiple Endocrine Neoplasia (MEN) Syndromes: Genetics, Clinical Heterogeneity and Modifying Genes 11
Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia 9
Transient erythroblastopenia of childhood after COVID-19 infection: a case report 8
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial 6
Hearing loss in beta-thalassaemia: An Italian multicentre case-control study 2
Pain Frequency and Health Care Utilization Patterns in Women with Sickle Cell Disease Experiencing Menstruation-Associated Pain Crises 2
null 1
GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia 1
Totale 1.738
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.130
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020106 0 0 0 0 13 9 22 3 14 4 35 6
2020/2021141 7 7 8 17 14 16 22 6 6 12 24 2
2021/2022279 6 4 5 4 61 10 31 25 18 7 20 88
2022/2023578 55 22 22 28 57 54 3 19 287 7 13 11
2023/2024235 19 7 18 14 63 47 4 5 5 0 19 34
2024/2025161 2 7 5 20 127 0 0 0 0 0 0 0
Totale 1.738